http://www.epo.org/law-practice/case-law-appeals/recent/t121050eu1.html
Content reproduced from the Website of the European Patent Office as permitted by their terms of use.
Download and more information: Decision text in EN (PDF, 493.755K).
Documentation of the appeal procedure can be found in the Register.

Online on: 27.04.2018
| Board: 3.3.01
| Decision date: 22.1.2018
| Proc. language: EN
| IPC: A61K 35/34, C12N 5/08, A61P 13/02
| Application no.: 05000057

Keywords: Referral to the Enlarged Board of Appeal – (no), Remittal to the department of first instance – (no), Novelty – (no), – meeting abstracts available to library users before priority date, – enabling disclosure for medical indication, Amendments – intermediate generalisation, Late-filed auxiliary requests

Application title: Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence